Stefan Floess

Title: The Innovations of Stefan Floess

Introduction

Stefan Floess is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of immunology, particularly in the detection and quality control of regulatory T cells. His innovative work has implications for both research and clinical applications.

Latest Patents

Stefan Floess holds a patent for a method related to the detection and quality control of regulatory T cells through DNA-methylation analysis of the Foxp3 gene. This invention provides an in vitro method for identifying FoxP3-positive regulatory T cells, specifically CD25CD4 regulatory T cells of mammals. The method involves analyzing the methylation status of at least one CpG position in the Foxp3 gene or its orthologous or paralogous genes. Additionally, the invention includes a kit designed for performing these methods, along with respective uses.

Career Highlights

Throughout his career, Stefan Floess has worked with prominent organizations such as Epiontis GmbH and Charité - Universitätsmedizin Berlin. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Stefan has collaborated with notable colleagues, including Jochen Huehn and Alf Hamann. These partnerships have further enhanced his research and innovation in the field of immunology.

Conclusion

Stefan Floess is a distinguished inventor whose work in the detection and quality control of regulatory T cells has made a significant impact in immunology. His innovative methods and collaborations continue to advance the field and improve our understanding of immune regulation.